Strength

100; 62.5; 25 ug/1; ug/1; ug/1

NDC

00173088714

Classification

Brand

Dosage Form

POWDER

Route

RESPIRATORY (INHALATION)

Last Updated

1/1/2026

Approval Type

New Drug (NDA)

FDA Application

NDA209482

On Market Since

9/18/2017

Pharmacological Classes

Adrenergic beta2-Agonists
Anticholinergic
Cholinergic Antagonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid
beta2-Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

+3.1%

3Y

+8.7%

5Y

+16.1%

All

+32.0%